Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (255)	1/30/2003 4:10:34 PM
From: Jibacoa	Respond to of 3722

AFFX Closed up 19.40% at 26.03 well over its January 14 H of 25.39 and in spite of some down ticks in the last few minutes<g> it has shown no intention of closing its early up-gap. Today's volume of 5,733,599 was higher than the July 3 volume of 4,485,900 and the May 15 volume of 5,376,200(both those days were "down days" and on May 15 there was a significant minus money flow of 1,151,600 The H that day was 26.35and today's was 26.39 <g> ) The stock announced today its deal with Roche,which looks like it should really open up the penetration of its technology into the mainstream diagnostic markets. Under the terms of the non-exclusive accord,Roche will pay AFFX a $70 M upfront fee and use its patented GeneChip technology for up to 18 years. AFFX should also get royalties on sales of diagnostics kits and milestone payments for "technical and commercial achievements".<g> siliconinvestor.com Bernard